here's-what-revolution-medicines,-inc.'s-(nasdaq:rvmd)-shareholder-ownership-structure-looks-like

Here's What Revolution Medicines, Inc.'s (NASDAQ:RVMD) Shareholder Ownership Structure Looks Like

NASDAQ:RVMD) have power over the company. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. Companies that have been privatized tend to have low insider ownership.” data-reactid=”28″ type=”text”>The big shareholder groups in Revolution Medicines, Inc. (NASDAQ:RVMD) have power over the company. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. Companies that have been privatized tend to have low insider ownership.

Revolution Medicines has a market capitalization of US$1.9b, so we would expect some institutional investors to have noticed the stock. Our analysis of the ownership of the company, below, shows that institutional investors have bought into the company. Let’s delve deeper into each type of owner, to discover more about Revolution Medicines.

See our latest analysis for Revolution Medicines ” data-reactid=”30″ type=”text”> See our latest analysis for Revolution Medicines

ownership-breakdown

What Does The Institutional Ownership Tell Us About Revolution Medicines?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

We can see that Revolution Medicines does have institutional investors; and they hold a good portion of the company’s stock. This suggests some credibility amongst professional investors. But we can’t rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It’s therefore worth looking at Revolution Medicines’ earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth

We note that hedge funds don’t have a meaningful investment in Revolution Medicines. Third Rock Ventures, LLC is currently the company’s largest shareholder with 19% of shares outstanding. The second and third largest shareholders are The Column Group LLC and FMR LLC, with an equal amount of shares to their name at 12%. In addition, we found that Mark Goldsmith, the CEO has 1.0% of the shares allocated to his name

On looking further, we found that 52% of the shares are owned by the top 5 shareholders. In other words, these shareholders have a meaningful say in the decisions of the company.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of Revolution Medicines

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

check here to see if those insiders have been buying recently. ” data-reactid=”72″ type=”text”>I can report that insiders do own shares in Revolution Medicines, Inc.. The insiders have a meaningful stake worth US$31m. Most would see this as a real positive. It is good to see this level of investment by insiders. You can check here to see if those insiders have been buying recently.

General Public Ownership

With a 21% ownership, the general public have some degree of sway over Revolution Medicines. While this group can’t necessarily call the shots, it can certainly have a real influence on how the company is run.

Private Equity Ownership

With an ownership of 31%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

Public Company Ownership

We can see that public companies hold 5.1% of the Revolution Medicines shares on issue. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. This holding is probably worth investigating further.

Next Steps:

2 warning signs we think you should be aware of.” data-reactid=”80″ type=”text”>I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example – Revolution Medicines has 2 warning signs we think you should be aware of.

report on analyst forecasts.” data-reactid=”81″ type=”text”>If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected].” data-reactid=”83″ type=”text”>

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected].

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top